BioNTech (SE) BNTX – Options Recap:
Yesterday morning, our premarket report featured a couple of options ideas, one of which was in BNTX. This came right on the heels of the company’s revelation that its COVID-19 vaccine developed in partnership with Pfizer has demonstrated a 100% efficacy rate in adolescent recipients.
That news provided at least some of the impetus for for our targets, the BNTX Weekly $99-101 Calls, to produce the following multibag intraday gain opportunities for anyone who caught our alert:
BNTX Weekly $99-101 Calls
$99: 2.90-7.00 (+141%)
$100: 2.15-6.80 (+216%)
$101: 2.30-5.30 (+130%)
We’ll be looking to extend these gains once again today, and will roll up to include the BNTX Weekly $105-107 Calls in our watchlist for the remainder of this short week.
AbCellera Biologics, Inc. ABCL – Our other fresh options idea from yesterday was a longer-term target with a couple weeks still remaining until expiration, but we saw instant results after calling the timing of the reversal perfectly:
ABCL 04/16 $25 Calls
$25: 1.75-3.00 (+71%)
Fresh Options Ideas:
CHWY Weekly $90-93 Calls
LULU Weekly $315-310 Puts
WBA Weekly $53-54 Calls
RSCF, INND, KYNC, TMGI, INKW, FTXP, BTDG